New bacterial species may help fight obesity and metabolic disorders

Source: Reviewed by Alina Shrourou, B.Sc. (Editor)Dec 17 2018The MyNewGut project has discovered new bacterial species and strains in healthy people that seem to be effective against obesity, metabolic and mental disorders related to stress and obesity (e.g. depression). They do so by influencing the endocrine and immune pathways that have an impact on both our physical and mental health.The bacterial strain ‘Bacteroides uniformis CECT 7771’ has shown pre-clinical efficacy on metabolic and immune dysfunctions in obesity, for example reducing serum triglyceride levels, glucose intolerance and body weight gain as well as inflammationBifidobacterium pseudocatenulatum CECT 7765 was shown to reduce depressive-like behavior associated with obesity in pre-clinical trials. A Bifidobacterium longum strain has been demonstrated to have a positive impact on perceived stress, sleep quality and cortisol release in a double-blinded placebo-controlled intervention trial in humans.These strains could potentially be next generation probiotics that could in the future be used to help tackle obesity and depression.How diet has an influence on the gut microbiotaDiet appears to be a major factor that influences the composition of the human gut microbiota. MyNewGut experts have conducted several human intervention trials to investigate dietary health effects potentially mediated by the microbiota and they are publishing a range of position papers that will show evidence on how we could inform future dietary recommendations. MyNewGut partners have specifically looked into the role played by proteins, fats and fibers on the gut microbiota.High intake of proteins or a high fat diet may harm the gut microbiotaMyNewGut partners found out that high protein consumption, which increases protein fermentation in the large intestine, generates some of the toxic metabolites (products of metabolism) linked to diseases such as colorectal cancer.A high fat diet, especially when rich in saturated fatty acids may have negative effects on the gut microbiota, characterized by a lower number of microbes and a lower variety of microbial species. High-fat diets rich in omega 3 or omega 6 polyunsaturated fatty acids do not seem to negatively affect the microbiota, whereas the effects of monounsaturated fatty acids are less consistent.High fat diets are associated with depressionStudies of the MyNewGut partners showed that Western diets rich in saturated fat resulted not only in obesity, but also in depression-like behavior. The depression-like behavior associated with diet-induced obesity depended on the gut microbiome, because the effects were blunted by antibiotic-treatment. In high-fat diet fed mice, using the same mouse model, MyNewGut also showed that a bacterial strain (Bifidobacterium pseudocatenulatum CECT 7765) reduces depressive-like behavior associated with obesity, acting through the gut-brain axis. These results are only a starting point, and new research would have to confirm the findings in humans.Related StoriesLSU Health researchers to investigate link between breast cancer and obesity in real timeUranium toxicity might have caused obesity and diabetes in Kuwait, finds new studyMaternal obesity may negatively affect children’s lung developmentThe role of the gut in metabolic healthStudies in animal models conducted by project partners have revealed new mechanisms whereby the microbiota could impact metabolic health. MyNewGut partners showed that peptidase activity (DPPIV) responsible for the degradation of enteroendocrine hormones produced in the gut, which regulate appetite and glucose homeostasis (like glucagon-like peptide I [GLP-I]), are of bacterial origin. This means that the presence of specific bacteria producing these new enzymes can adversely influence appetite, food intake and body weight gain.Gut microbiota: we are all different The MyNewGut project has also explored innovative interventions, including Faecal Microbiota Transplants (FMT) for restoring dysbiosis-associated disorders. In FMT, the microbiota of a healthy donor is transferred to an individual suffering from some form of dysbiosis.In MyNewGut studies, the donor’s microbiota was transferred to human subjects with metabolic syndrome. In these studies, the responsiveness to treatment depended on the individual’s gut microbiota profile, suggesting a need for personalized intervention strategies. This study demonstrates that the individual’s microbiota directly impacts neural systems that could mediate the impact of food intake on metabolic health.The impact of early life microbial imbalance on healthMyNewGut partners investigated whether effects of environmental factors in early life and childhood also impact health outcomes in later stages of life in humans. For example, they conducted a longitudinal study in children to determine the role of the microbiota, the lifestyle (diet, exercise, etc.) and other individual factors (immune and metabolic profile) in the development of overweight.The study revealed that specific microbiota configurations were indeed correlated to inflammatory markers and dietary patterns, and subsequently to the development of obesity.MyNewGut has also discovered that dietary changes which favorably influence the microbiota may have a higher and longer-lasting effect during stages of development, and this emphasizes the importance of diet during early life for long-term health in adulthood.

Leave a Reply

Your email address will not be published. Required fields are marked *